A Connecticut jury awarded $4 million in compensatory damages, plus punitive damages, to a breast cancer survivor against Wyeth, Inc. today at the U.S. District Court in New Haven.
The jury found: Wyeth’s hormone-replacement therapy drug Prempro caused the Plaintiff’s invasive breast cancer; Wyeth failed to provide adequate warnings or instructions regarding the known or knowable risk of breast cancer associated with Prempro; Prempro was an unreasonably dangerous product; Wyeth was negligent in its testing, studying, and investigating the risks; and Wyeth negligently misrepresented the risks and benefits of the drug.
Jurors began deliberations around 2:30 p.m. April 17, and came in with the verdict at 1:00 p.m. April 18. The case was tried by Attorneys Gregory Bubalo of Bubalo Law PLC with Attorney Neal Moskow of Ury & Moskow, LLC. (Link to original news release.)